Prognostic features of splenic lymphoma with villous lymphocytes: A report on 129 patients

British Journal of Haematology

Volumn 120, Issue 5, 2003, Pages 759-764

  Parry Jones, Nilima ^a,b   Matutes, Estella ^a,b   Gruszka Westwood, Alicja M ^a,b   Swansbury, G John ^a,b   Wotherspoon, Andrew C ^a,b   Catovsky, Daniel ^a,b,c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Clinical features; Prognostic features; SLVL; Splenectomy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DAUNORUBICIN DERIVATIVE; ETOPOSIDE; FLUDARABINE; HEMOGLOBIN; HYDROXYDAUNORUBICIN; MITOXANTRONE; PLASMA PROTEIN; PREDNISOLONE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; AGE; AGED; ANEMIA; ARTICLE; B CELL LYMPHOMA; BENIGN TUMOR; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HEPATOMEGALY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LYMPHADENOPATHY; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SPLEEN BIOPSY; SPLENECTOMY; SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTE; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; SPLENECTOMY; SPLENIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037335652     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04165.x     Document Type: Article

References (18)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1989) Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. Journal of Clinical Pathology, 42, 567-584.
2. Camacho, F.I., Mollejo, M., Mateo, M.S., Algara, P., Navas, C., Hernandez, J.M., Santoja, C., Sole, F., Sanchez-Beato, M. & Piris, M.A. (2001) Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. American Journal of Surgical Pathology, 25, 1268-1276.
3. Catovsky, D., Fooks, J. & Richards, S. (1989) Prognostic factors in chronic lymphocytic leukaemia: the importance of age. sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults. British Journal of Haematology, 72, 141-149.
4. Catovsky, D. & Matutes, E. (1999) Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Seminars in Hematology, 36, 148-154.
5. Chacon, J.I., Mollejo, M., Munoz, E., Algara, P., Mateo, M., Lopez, L., Andrade, J., Carbonero, I.G., Martinez, B., Piris, M.A. & Cruz, M.A. (2002) Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood, 100, 1648-1654.
6. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society. 34, 187-220.
7. Gruszka-Westwood, A.M., Matutes, E., Coignet, L.J., Wotherspoon, A. & Catovsky, D. (1999) The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH. British Journal of Haematology, 104, 600-604.
8. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Fallni, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
9. Hermine, O., Lefrere, F., Bronowicki, J.P., Mariette, X., Jondeau, K., Eclache-Saudreau, V., Delmas, B., Valensi, F., Cacoub, P., Brechot, C., Varet, B. & Troussard, X. (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. New England Journal of Medicine, 347. 89-94.
10. Isaacson, P.G., Matutes, E., Burke, M. & Catovsky, D. (1994) The histopathology of splenic lymphoma with villous lymphocytes. Blood, 84, 3828-3834.
11. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. IARC Press, Lyon.
12. Matutes, E., Morilla, R., Owusu-Ankomah, K., Houlihan, A. & Catovsky, D. (1994a) The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood, 83, 1558-1562.
13. Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Oue, T.H. & Catovsky, D. (1994b) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia, 8, 1640-1645.
14. Melo, J.V., Hegde, U., Parreira, A., Thompson, I., Lampert, I.A. & Catovsky, D. (1987) Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. Journal of Clinical Pathology, 40, 642-651.
15. Mulligan, S.P., Matutes, E., Dearden, C. & Catovsky, D. (1991) Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. British Journal of Haematology, 78, 206-209.
16. Neiman, R.S., Sullivan, A.L. & Jaffe, R. (1979) Malignant lymphoma simulating leukemic reticuloendotheliosis: a clinicopathologic study of ten cases. Cancer, 43, 329-342.
17. Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., Mcpherson, K., Peto, J. & Smith, P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer, 35, 1-39.
18. Troussard, X., Valensi, F., Duchayne, E., Garand, R., Felman, P., Tulliez, M., Henry-Amar, M., Bryon, P.A. & Flandrin, G. (1996) Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC). British Journal of Haematology, 93, 731-736.